You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
Order to Cease Manufacturing of HCT/Ps - New York Fertility Institute
Posted: 3/13/2013
FDA Safety Communication: Safety risk from reproductive tissue at the New York Fertility Institute of New York, New York
Posted: 3/13/2013
CBER-WHO Cooperative Agreement: Innovations in Vaccine Clinical Trials and Pharmacovigilance
Posted: 3/13/2013
CBER-WHO Cooperative Agreement: Supporting Influenza Vaccine Introduction to Low-Middle Income Countries
Posted: 3/13/2013
WHO Cooperative Agreements
Updated: 3/13/2013
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
